Verrica Pharmaceuticals Inc. Contracts & Agreements

Amendment to 2024 Inducement Plan (Filed With SEC on December 9, 2024)

Offer Letter, dated December 5, 2024, by and between the Company and David Zawitz (Filed With SEC on December 9, 2024)

Form of Series B Warrant (Filed With SEC on November 21, 2024)

Form of Series A Warrant (Filed With SEC on November 21, 2024)

Form of Pre-Funded Warrant (Filed With SEC on November 21, 2024)

Underwriting Agreement, dated November 20, 2024, by and between the Company and Jefferies LLC (Filed With SEC on November 21, 2024)

Release and Consulting Agreement, dated as of August 30, 2024, by and between the Registrant and Joseph Bonaccorso (Filed With SEC on November 5, 2024)

Fifth Amendment to Credit Agreement, dated as of August 2, 2024, by and between the Registrant and OrbiMed Royalty & Credit Opportunities IV, LP (Filed With SEC on November 5, 2024)

Professional Services Agreement, dated November 4, 2024, by and between the Company and John J. Kirby (Filed With SEC on November 4, 2024)

Form of Stock Option Grant Notice and Stock Option Agreement under 2024 Inducement Plan (Filed With SEC on November 4, 2024)

Form of Restricted Stock Unit Award Grant Notice and Award Agreement under 2024 Inducement Plan (Filed With SEC on November 4, 2024)

Verrica Pharmaceuticals, Inc. 2024 Inducement Plan (Filed With SEC on November 4, 2024)

Offer Letter, dated November 4, 2024, by and between the Company and Jayson Rieger (Filed With SEC on November 4, 2024)

Release Agreement, dated November 4, 2024, by and between the Company and Ted White (Filed With SEC on November 4, 2024)

First Amendment to Collaboration and License Agreement, dated as of May 14, 2024, by and between the Registrant and Torii Pharmaceuticals Co., Ltd (Filed With SEC on August 14, 2024)

Fifth Amendment to Credit Agreement, dated as of August 2, 2024, by and between the Registrant and OrbiMed Royalty & Credit Opportunities IV, LP (Filed With SEC on August 14, 2024)

Fourth Amendment to Credit Agreement, dated as of June 26, 2024, by and between the Registrant and OrbiMed Royalty & Credit Opportunities IV, LP (Filed With SEC on August 14, 2024)

Third Amendment to Credit Agreement, dated as of May 6, 2024, by and between the Registrant and OrbiMed Royalty & Credit Opportunities IV, LP (Filed With SEC on August 14, 2024)

Warrant to Purchase Common Stock, dated as of May 14, 2024, by and between the Registrant and Torii Pharmaceuticals Co., Ltd (Filed With SEC on August 14, 2024)

Second Amended and Restated Non-Employee Director Compensation Policy, adopted by the Board as of February 27, 2024 (Filed With SEC on February 29, 2024)

First Amendment to Credit Agreement, dated as of December 20, 2023, by and between the Registrant and Orbimed Royalty & Credit Opportunities IV, LP (Filed With SEC on February 29, 2024)

Second Amendment to Credit Agreement, dated as of January 31, 2024, by and between the Registrant and Orbimed Royalty & Credit Opportunities IV, LP (Filed With SEC on February 29, 2024)

Underwriting Agreement, dated February 21, 2023, by and between the Company and Jefferies LLC (Filed With SEC on February 21, 2023)

Form of Pre-Funded Warrant (Filed With SEC on February 21, 2023)

Underwriting Agreement by and between Verrica Pharmaceuticals Inc. and RBC Capital Markets, LLC, dated June 29, 2022 (Filed With SEC on July 1, 2022)

Waiver and Second Amendment to Loan and Security Agreement, dated as of March 1, 2022 (Filed With SEC on March 2, 2022)

Waiver and Second Amendment to Mezzanine Loan and Security Agreement, dated as of March 1, 2022 (Filed With SEC on March 2, 2022)

Employment Agreement, by and between the Registrant and Christopher Hayes, dated as of February 27, 2020 (Filed With SEC on March 2, 2022)

Employment Agreement by and between the Registrant and Gary Goldenberg, dated as of August 1, 2020 (Filed With SEC on March 2, 2022)

Amended and Restated Non-Employee Director Compensation Policy, adopted by the Board as of February 24, 2022 (Filed With SEC on March 2, 2022)

Employment Agreement, by and between Verrica Pharmaceuticals Inc. and Terry Kohler, dated July 16, 2021 (Filed With SEC on November 12, 2021)

Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on August 10, 2021)

Collaboration and License Agreement, by and between the Company and Torii Pharmaceutical Co., Ltd., dated March 17, 2021 (Filed With SEC on May 7, 2021)

Underwriting Agreement by and among Verrica Pharmaceuticals Inc., Jefferies LLC, Cowen and Company, LLC and RBC Capital Markets, LLC, dated March 22, 2021 (Filed With SEC on March 23, 2021)

First Amendment to Loan and Security Agreement, by and between the Company and Silicon Valley Bank, dated as of October 26, 2020 (Filed With SEC on March 17, 2021)

First Amendment to Mezzanine Loan and Security Agreement, by and among the Company, Silicon Valley Bank and WestRiver Innovation Lending Fund VIII, L.P., dated as of October 26,... (Filed With SEC on March 17, 2021)

Exclusive License Agreement, by and between the Registrant and Lytix Biopharma AS, dated as of August 7, 2020 (Filed With SEC on November 9, 2020)

Second Amendment to Lease Agreement, by and between the Registrant and 44 West Gay LLC, dated as of April 27, 2020 (Filed With SEC on August 5, 2020)

First Amendment to Lease Agreement, by and between the Registrant and 44 West Gay LLC, dated as of March 12, 2020 (Filed With SEC on May 7, 2020)

Mezzanine Loan and Security Agreement, by and among the Company, Silicon Valley Bank and WestRiver Innovation Lending Fund VIII, L.P., dated as of March 10, 2020 (Filed With SEC on May 7, 2020)

Loan and Security Agreement, by and between the Company and Silicon Valley Bank, dated as of March 10, 2020 (Filed With SEC on May 7, 2020)

Amended and Restated Employment Agreement, by and between the Registrant and Patrick Burnett, dated as of January 10, 2020 (Filed With SEC on March 13, 2020)

Amended and Restated Employment Agreement, by and between the Registrant and Joe Bonaccorso, dated as of January 10, 2020 (Filed With SEC on March 13, 2020)

Amended and Restated Employment Agreement, by and between the Registrant and Ted White, dated as of January 10, 2020 (Filed With SEC on March 13, 2020)

Description of Verrica Pharmaceuticals Inc. Common Stock (Filed With SEC on March 13, 2020)

Third Amendment to Services Agreement, by and between the Company and PBM Capital Group, LLC, dated as of October 1, 2019 (Filed With SEC on November 6, 2019)

Offer Letter, by and between the Company and Brian Davis, dated as of October 4, 2019 (Filed With SEC on October 10, 2019)

Lease Agreement dated July 1, 2019 between the Company and 44 West Gay LLC (Filed With SEC on July 1, 2019)

Second Amendment to Services Agreement, by and between the Registrant and PBM Capital Group, LLC, dated as of January 1, 2019 (Filed With SEC on March 7, 2019)

Supply Agreement, by and between the Company and Funing County Development Brucea Javanica Professional Cooperatives, dated as of July 16, 2018 (Filed With SEC on November 7, 2018)

Form of Underwriting Agreement (Filed With SEC on June 5, 2018)

Form of 2018 Equity Incentive Plan (Filed With SEC on June 5, 2018)

Form of Stock Option Grant Notice, Stock Option Agreement, Restricted Stock Unit Grant Notice, and Restricted Stock Unit Award Agreement under 2018 Equity Incentive Plan (Filed With SEC on June 5, 2018)

Non-Employee Director Compensation Policy (Filed With SEC on June 5, 2018)

Transition Agreement, by and between the Registrant and Matt Davidson, effective as of May 31, 2018 (Filed With SEC on June 5, 2018)

Form of Indemnification Agreement with Executive Officers and Directors (Filed With SEC on May 22, 2018)

Amended and Restated Investors Rights Agreement by and among the Registrant and certain of its stockholders, dated February 20, 2018 (Filed With SEC on May 22, 2018)

2013 Equity Incentive Plan, as amended (Filed With SEC on May 22, 2018)

Form of Stock Option Grant Notice and Stock Option Agreement under 2013 Equity Incentive Plan (Filed With SEC on May 22, 2018)

Sublease Agreement, by and between Therakos, Inc. and the Registrant, dated as of April 9, 2018 (Filed With SEC on May 22, 2018)

Employment Agreement, by and between the Registrant and Ted White, dated as of December 11, 2017 (Filed With SEC on May 22, 2018)

Employment Agreement, by and between the Registrant and Chris Degnan, dated as of February 7, 2018, as amended on February 14, 2018 (Filed With SEC on May 22, 2018)

Employment Agreement, by and between the Registrant and Linda Palczuk, dated as of January 30, 2018, as amended on February 13, 2018 (Filed With SEC on May 22, 2018)

Employment Agreement, by and between the Registrant and Joe Bonaccorso, dated as of January 6, 2018, as amended on January 29, 2018 (Filed With SEC on May 22, 2018)

Employment Agreement, by and between the Registrant and Matt Davidson, dated as of December 2, 2015 (Filed With SEC on May 22, 2018)

Services Agreement, by and between the Registrant and PBM Capital Group, LLC, dated as of December 2, 2015, as amended on March 29, 2018 (Filed With SEC on May 22, 2018)

Advisor Agreement, by and between the Registrant and Glenn Oclassen, dated as of August 7, 2014 (Filed With SEC on May 22, 2018)

Amended and Restated Restricted Stock Purchase Agreement, by and between the Registrant and Matthew Davidson, dated as of December 2, 2015 (Filed With SEC on May 22, 2018)

Restricted Stock Purchase Agreement, by and between the Registrant and Glenn Oclassen, dated as of August 7, 2014, as amended on January 31, 2018 (Filed With SEC on May 22, 2018)

Employment Agreement, by and between the Registrant and Patrick Burnett, dated as of March 7, 2018, as amended (Filed With SEC on May 22, 2018)

Category

Industry

Companies

Contracts

Verrica Pharmaceuticals Inc. Contracts & Agreements